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Abstract
Essential hypertension (EH) is a complex disease in which physiological, environmental, and genetic factors are involved in its genesis.
The genetic variant of the alpha-adducin gene (ADD1) has been described as a risk factor for EH, but with controversial results.
The objective of this study was to evaluate the association of ADD1 (Gly460Trp) gene polymorphismwith the EH risk in a population
from Madeira Island.
A case-control study with 1614 individuals of Caucasian origin was performed, including 817 individuals with EH and 797 controls.
Cases and controls were matched for sex and age, by frequency-matching method. All participants collected blood for biochemical
and genotypic analysis for the Gly460Trp polymorphism. We further investigated which variables were independently associated to
EH, and, consequently, analyzed their interactions.
In our study, we found a significant association between the ADD1 gene polymorphism and EH (odds ratio 2.484, P= .01). This
association remained statistically significant after the multivariate analysis (odds ratio 2.548, P= .02).
The ADD1 Gly460Trp gene polymorphism is significantly and independently associated with EH risk in our population. The
knowledge of genetic polymorphisms associated with EH is of paramount importance because it leads to a better understanding of
the etiology and pathophysiology of this pathology.
Abbreviations: ADD1 = alpha-adducin gene, BMI = body mass index, CI = confidence interval, DBP = diastolic blood pressure,
EH = essential hypertension, GENHYMAPE = Genes and Hypertension in Madeira, Gly = glycine, HDL-C = high-density lipoprotein
cholesterol, LDL-C = low-density lipoprotein cholesterol, MDR = multifactorial dimensionality reduction, OR = odds ratio, PCR =
polymerase chain reaction, SBP = systolic blood pressure, Trp = tryptophan.
Keywords: ADD1 Gly460Trp gene polymorphism, case-control study, essential hypertension1. Introduction
Essential hypertension (EH) affects one-quarter of adults
worldwide, and is estimated to increase to one-third by
2025.[1] Its overall prevalence in the Portuguese adult population
is about 42%, of which 44.4% is in men and 40.2% in women.[2]Editor: Leonardo Roever.
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1Several meta-analyses have demonstrated consistently and
linearly that elevated blood pressure (BP) is a powerful risk
factor for cardiovascular disease and progression to renal failure,
independently of other vascular risk factors. Persistently high BP
values lead to cardiac, vascular, and renal disease.[3,4]
Essential hypertension is a complex and multifactorial disorder
resulting from environmental and genetic factors, and their
interactions.[5] Epidemiological studies have shown that 20% to
40% of BP variation is genetically determined.[6,7] In the last
decades, many efforts have been made to clarify the pathophysi-
ological mechanisms of hypertension.
Several genetic variants have been studied and associated with
the development of EH.[8] However, the molecular genetics of EH
remains unclear.
Cusi et al[9] first described a genetic variant at alpha-adducin
(ADD1) gene level, which resulted from a glycine (Gly) to
tryptophan (Trp) substitution at amino acid position 460
(Gly460Trp).[9] This genetic variant Gly460Trp modulates the
overall ability of tubular epithelial cells to transport ions, leading
to an increased Na+/K+-ATPase pump activity and thus to a
greater sodium reabsorption at the proximal renal tubule,
increasing, consequently, the BP.[9–11]
The association of this genetic variant with hypertension was
confirmed in some studies,[12–15] but not in others.[16–19]
The purpose of this study was to evaluate the association
between the ADD1 Gly460Trp polymorphism and EH in a
Sousa et al. Medicine (2017) 96:42 Medicinecohort from Madeira Island. The identification of these causal
and/or associated variants promotes the development of
approaches for EH prediction and prevention.2. Material and methods
2.1. Study population
All individuals were selected from Genes and Hypertension in
Madeira (GENHYMAPE) study,[20] an ongoing Madeira
population-based study which started in 2006, and consists of
adults aged 30 to 75 years. It is a hospital-based case-control
study, with patients enrolled from Cardiology consultations and
controls selected from the Internal Medicine, on condition that
they were normotensive and matched for sex and age.
Its purpose is to identify determinants of essential hypertension
inMadeira Island (Portugal). This Island is located on the African
plate, in the Atlantic Ocean, between 30° and 33° north latitude,
978km southwest of Lisbon, about 700km west of the African
coast.
Participants of this study include native inhabitants and
residents in Madeira Island for at least 3 generations with no
migration history, from both rural and urban origins. This
population is considered a genetically fairly homogeneous South
European Caucasian population.
2.2. Study design
This case-control study was performed with a total of 1614
individuals with a mean age of 50.6±8.2 years (50.1% male),
namely 817 patients diagnosed with EH (mean age 50.8±8.1
years; 51.5% male) and 797 normotensive controls (mean age of
50.4±8.3 years; 48.6% male).
This study was approved by the ethics committee of the
Funchal Hospital Center, and was performed in conformity with
the guidelines outlined in the Declaration of Helsinki statement.
Written informed consent was obtained from each participant,
including explicit permission for the DNA analyses and the
collection of relevant clinical data.
2.3. Data collection
Data were collected from all subjects in a standardized file
comprising demographic, clinical characteristics, and traditional
risk factors (sex, age, sedentary lifestyle, smoking and alcohol
habits, body mass index [BMI], diabetes, and dyslipidemia). The
definition of the traditional risk factors was based on the standard
criteria, as previously reported.[21–24]
Sedentary lifestyle was considered when individuals practiced
less than 150min/wk of moderate activity.[21] Alcohol consump-
tion was considered as a risk factor when individuals consumed
70g of alcohol per week for more than 1 year. “Smoking status”
refers to current smokers or subjects with less than 5 years of
smoking cessation.[21] BMI was defined as body mass divided by
the square of the body height, universally expressed in units of kg/
m2, with obesity defined as a BMI ≥30.[22]
Subjects were classified as being diabetic when taking oral
antidiabetic medication or insulin, or if their fasting plasma
glucose was higher than 7.0mmol/L or 126mg/dL.[23]2.4. Definition of essential hypertension
Blood pressure was measured by an Internal Medicine specialist,
after 10minutes of resting, in the right arm, using a standard2Welch Allyn sphygmomanometer (phases I through V). The
average of 3 readings taken 2minutes apart was recorded.[25]
Essential hypertension was considered when patients, at the
entry into this study, were already diagnosed and/or had been on
antihypertensive medication for more than 3 months or newly
diagnosed hypertensives with systolic BP (SBP)/diastolic BP
(DBP) ≥140/90mm Hg measured on at least 3 occasions.[25]
The normotensive controls had never been treated with
antihypertensive medications, and presented with SBP/DBP
<140/90mm Hg. In addition, subjects with secondary hyperten-
sion, pregnant and lactating females, and those receiving
medications for other indications that could affect BP were
excluded from this study. Participants with multiple organ
failure, a mental disorder, or chronic inflammatory disease were
also excluded from this study.2.5. Biochemical analyses
Blood samples were extracted after 14 to 16 hours of fasting.
Biochemical analyses were performed in the Central Laboratory
of the Hospital, according to the usual techniques.
To determine total cholesterol and triglycerides, blood samples
were placed in dry tubes and centrifuged half an hour later at
3500g, and subsequently quantified by an enzymatic technique
using a Hitachi 911 auto analyzer.2.6. Genotype analysis
Genomic DNA was extracted from 80mL of peripheral blood
using a standard phenol-chloroform method. To identify ADD1
genotypes, a TaqMan allelic discrimination assay was performed
using labelled probes and primers pre-established by the supplier
(TaqMan SNP Genotyping Assays, Applied Biosystems).
The genotyping reaction was amplified and detected on an
Applied Biosystems 7300 Real-Time PCR System, and genotypes
were determined by using the 7300 System SDS Software
(Applied Biosystems, Foster City, CA) without any prior
knowledge of individual clinical data.2.7. Statistical analysis
Deviation from Hardy–Weinberg equilibrium for genotypes at
individual locus was assessed using the chi-square test.
Comparisons of characteristics between cases and controls were
analyzed by chi-square test for categorical variables and Student t
test or Mann–Whitney U test for continuous variables, as
appropriate. No missing data were observed.
The case-control matching procedure was based upon the
distributions of the characteristics among the cases, named
“frequency-matching.”
Genotypic frequencies were determined from observed counts
and compared by chi-square analysis. Three statistical genetic
models were tested, namely additive (distribution of Trp allelic
frequency of ADD1), recessive (TrpTrp vs GlyGly+GlyTrp), and
dominant (GlyGly vs GlyTrp+ TrpTrp). The odds ratio (OR) and
corresponding 95% confidence interval (CI) were determined.
A multivariate logistic regression model was performed using
forward Wald method to examine associations between ADD1
genotypes and to account for significant risk factors as described
(sex, age, smoking status, alcohol consumption, BMI, diabetes,
sedentary lifestyle). The environmental risk factors were further
studied for their interaction with ADD1 polymorphism by using
multifactorial dimensionality reduction (MDR) 3.0.2 software.
Table 1
Baseline characteristics of study subjects.
Variables Total (N=1614) Hypertensives (n=817) Controls (n=797) P
Male sex, n (%) 808 (50.1) 421 (51.5) 387 (48.6) .252
Age, y 50.6±8.2 50.8±8.1 50.4±8.3 .252
SBP, mm Hg 134.7±20.4 148.1±18.6 121±10.8 <.001
DBP, mm Hg 84.7±12 91.6±11.6 77.7±7.4 <.001
BMI, kg/m2 27.8±4.9 29.3±5.2 26.2±4 <.001
Sedentary lifestyle, n (%) 881 (54.6) 460 (56.3) 421 (52.8) .16
Alcohol consumption, n (%) 626 (38.8) 340 (41.6) 286 (35.9) .02
Smoking status, n (%) 320 (19.8) 135 (16.5) 185 (23.2) <.001
Diabetes, n (%) 169 (10.5) 133 (16.3) 36 (4.5) <.001
Dyslipidemia, n (%) 1336 (82.8) 715 (87.5) 621 (77.9) <.001
Total cholesterol, mg/dL 207 (107–370) 209 (115–344) 206 (107–370) .08
HDL-C, mg/dL 48 (17.2–111.7) 46.9 (17.2–103) 49 (20.8–111.7) <.001
LDL-C, mg/dL 131.1 (37.7–269) 131.1 (37.7–269) 131 (42–260) .94
Triglycerides, mg/dL 110 (21–1098) 122 (31–1098) 98 (21–688) <.001
Fasting glucose, mg/dL 95 (66–364) 98 (70–360. 93 (66–364) <.001
Statistically significant for P< .05.
BMI=body mass index, DBP=diastolic blood pressure, HDL-C=high-density lipoprotein cholesterol, LDL-C= low-density lipoprotein cholesterol, SBP= systolic blood pressure.
Sousa et al. Medicine (2017) 96:42 www.md-journal.comThe best combination pattern was searched on the principle that
both cross-validation consistency and test balance accuracy were
maximized to evaluate the interaction of the genetic polymor-
phism with the environmental risk factors, in relation to EH.
Statistical analysis was done using SPSS software version 19.0
(IBM, Armonk, NY) and R version 3.2.0. P value <.05 was used
as the level of significance.3. Results
3.1. Baseline characteristics of the population
The baseline characteristics of the study subjects are shown in
Table 1. This study included a total of 1614 individuals, namely
817 patients diagnosed with EH and 797 normotensive controls.
The case-control matching procedure was based upon the
“frequency-matching.” Specifically, using chi-square test, we
obtained a male frequency of 51.5% for cases and 48.6% for
controls, without statistical significance (P> .05), meaning that
no significant differences exist between the 2 groups. Addition-
ally, using Student t test, we obtained a mean (±SD) age of 50.8
(±8.1) years for cases and 50.4 (±8.3) years for controls, without
statistical significance (P> .05), showing that the variable age is
correctly adjusted for cases and controls (Table 1).
Sedentary lifestyle, total cholesterol, and low-density lipopro-
tein cholesterol (LDL-C) showed no significant differences
between cases and controls (all P> .05). However, SBP and
DBP, BMI, alcohol consumption, diabetes, dyslipidemia, triglyc-
erides, and fasting glucose were significantly higher in the
hypertensive group than in controls (P< .05).Table 2
Genotype distribution of ADD1 gene polymorphism among hypertens
ADD1 Gly460Trp Cases (n=817) Controls (n=797)
Gly/Gly, n (%) 573 (70.1) 572 (71.8)
Gly/Trp, n (%) 219 (26.8) 215 (27)
Trp/Trp, n (%) 25 (3.1) 10 (1.2)
Statistically significant for P< .05.
ADD1= alpha-adducin gene, CI= confidence interval, Gly=glycine, OR= odds ratio from the genetic ri
3Smoking and high-density lipoprotein cholesterol (HDL-C)
were higher in the control group, with statistical significance
(P= .001 and P< .001, respectively) (Table 1).
3.2. Genotype distribution of ADD1 (Gly460Trp) gene
polymorphism among cases and controls, and EH risk
The genotype distributions of ADD1 are shown in Table 2. In our
population, genotype distributions were in Hardy–Weinberg
equilibrium (P> .05). The wild genotype (GlyGly) was more
prevalent in controls than in cases (71.8% vs 70.1%). On the
contrary, the mutated genotype (TrpTrp) was more frequent in
cases than in controls (3.1% vs 1.2%) with statistical significance
(P= .01) (Table 2).
Risk prediction was evaluated under 3 genetic models of
inheritance (Table 2). The alfa-adducin Gly460Trp gene
polymorphism showed a statistical significant increase in EH
risk, under the recessive genetic model (odds ratio [OR] 2.484,
95% confidence interval [CI] 1.185–5.207, P= .01). No signifi-
cant association was found using a dominant genetic model (OR
1.083, 95% CI 0.873–1.342, P= .47) or additive model (OR
1.143, 95% CI 0.943–1.386, P= .17) (Table 2).
A multivariate analysis (logistic regression) was performed to
determine which variables were independently associated with EH
risk (Table 3). ADD1Try/Try genotype remained in the equation as
a significant and independent risk factor for EH (OR2.548, 95%CI
1.159–5.601,P= .02).Additionally, diabetes, alcohol consumption,
and BMI were also significantly associated with EH risk (Table 3).
Remarkably, smoking habits appeared in the equation as a
significant protective variable to EH development (Table 3).ive subjects and controls and essential hypertension risk.
Models (OR, 95% CI)
Dominant Recessive Additive
1.083 2.484 1.143
(0.873–1.342) (1.185–5.207) (0.943–1.386)
P= .47 P= .01 P= .17
sk models, with the recessive (in italics) showing the best results, Trp= tryptophan.
Table 3
Logistic regression analysis with variables independently asso-
ciated with essential hypertension.
Variables Odds ratio (95% CI) P
Diabetes 3.028 (2.026–4.526) <.001
Alcohol consumption 1.238 (.996–1.538) .05
BMI 1.163 (1.132–1.195) <.001
Smoking status .713 (.544–0.935) .01
ADD1 — .06
ADD1 (Gly/Trp) .965 (.761–1.225) .77
ADD1 (Trp/Trp) 2.548 (1.159–5.601) .02
0
Method forward Wald (SPSS version 19.0).
ADD1= alpha-adducin gene, BMI=body mass index, CI=confidence interval, Gly=glycine, Trp=
tryptophan.
Not remained in the equation: age, sex, and sedentary lifestyle.
Statistically significant for P< .05.
Sousa et al. Medicine (2017) 96:42 MedicineThe MDR software was finally employed to analyze the
interaction between the nongenetic variables and the ADD1
polymorphism (Table 4). The best association model included
diabetes, BMI, and ADD1 polymorphism, which showed a
maximal testing accuracy of 0.641 and a cross-validation
consistency of 10 out of 10 (Table 4). These results indicate
that ADD1 interacts with diabetes and BMI in a synergistic way,
with a 3.77-fold greater risk of EH (Table 4).4. Discussion
In our population from Madeira Island, subjects who were
carriers of the mutated ADD1 Trp460Trp genotype had an
increased risk of EH. This association was further strengthened in
the multivariate analysis, reinforcing the importance of this
variant in the susceptibility to EH in our population. Cusi et al[9]
published the first Caucasian study that has proved a significant
linkage between ADD1 Gly460Trp gene polymorphism and EH.
Similar results have also been found in others ethnicities, such as
Asians[12,15] and Africans.[14] Nevertheless, the association of the
ADD1 polymorphism with the susceptibility to EH was not
always clearly demonstrated.[16–19,26] The lack of association did
not exclude the involvement of this genetic variant with renal
sodium-handling abnormalities.
The ADD1 polymorphism results in the amino acid substitu-
tion of glycine by tryptophan (Gly460Trp), which is reported to
be associated with a salt sensitive form of hypertension patients.
Manunta et al[11] have studied the involvement of ADD1
polymorphism in abnormalities of renal function in hypertensive
patients, and have concluded that the fraction of excretions ofTable 4
Best models to analyze gene–environment interactions by multifacto
Best
model
Training
balanced accuracy
Training
odds ratio
Training
P
BMI 0.622 3.71 (2.88–4.77) <.001
Diabetes; BMI 0.638 3.76 (2.96–4.76) <.001
Diabetes; BMI; ADD1
∗
0.641 3.77 (2.98–4.77) <.001
Diabetes; BMI; smoking; ADD1 0.642 3.96 (3.12–5.03) <.001
Statistically significant for P< .05.
ADDI= alpha-adducin gene, BMI=body mass index.
∗
Overall best combination model with highest training balanced accuracy, highest testing accuracy, an
4lithium and uric acid, markers of proximal renal tubular
function, was reduced in patients with the alpha-adducin variant
TrpTrp. This supports the hypothesis that this variant is related
to an increase in proximal Na+ reabsorption at the kidney level[16]
by an increase in the Na+ pump activity and a higher number of
Na+ pump units expressed on the cell surface.[27]
Cusi et al[9] exposed hypertensive subjects to an acute salt
sensitivity test and investigated the effect of ADD1 polymorphism
on the response of acute BP to sodium changes. Authors
concluded that heterozygotes (Gly460Trp) had a greater decrease
in BP and significantly lower plasma renin activity than
homozygotes (Gly460Gly).[9]
This leads us to conclude that alpha-adducin 460Trp
polymorphism is associated with an increase in BP, not in all
hypertensive individuals,[14] but in the specific hypertensive
phenotype—salt-sensitive and low renin hypertension.
Other investigators have found decreased renin activity levels
in subjects carrying the 460Trp allele.[12,28]
Grant et al[29] showed that this genetic variant modifies sodium
homeostasis and associates with intermediate phenotypes of salt
sensitivity and low renin hypertension. This may be explained by
the fact that a deficient alpha-adducin function leads to increased
tubular sodium reabsorption, producing sodium retention and
intravascular volume expansion with suppression of plasma
renin activity.[29]
The genetic variance of 1 or more of these genes may justify the
increased salt sensitivity of some individuals; hence the
importance of their knowledge to individualize EH control
and therapeutic measures.
In addition to ADD1 Trp460Trp genotype, other variables
such as BMI, alcohol habits and diabetes remained in the
equation as independent risk factors of EH. According to our
results, smoking status appeared to be a protective factor. A likely
explanation of these apparent protective effects of smoking on
hypertension might be related to the fact that hypertensive
patients are most likely to have been advised by their physicians
to quit smoking, so that the proportion of smoking hypertensives
is lower than the proportion of nonsmoking ones. MDR analyses
further showed the interaction between ADD1 polymorphism,
BMI, and diabetes as the best model for EH susceptibility. Since
BMI plays a key role in development of high BP and ADD1 is 1 of
the most important targets for salt sensitivity and expanded
plasma volume, it is not surprising that their interaction may play
an important role in the susceptibility to hypertension. On the
contrary, it is now established that insulin resistance, which
predicts type 2 diabetes, also has a role in the development of
hypertension.[30] Indeed, hypertension and diabetes substantially
share common pathways such as obesity, inflammation, oxida-
tive stress, insulin resistance, and mental stress.r dimensionality reduction.
Testing
balanced accuracy
Testing
odds ratio
Testing
P
Cross
validation consistency
0.622 3.71 (1.73–7.92) .0005 10/10
0.638 3.76 (1.84–7.66) .0002 10/10
0.641 3.77 (1.87–7.62) .0001 10/10
0.629 3.44 (1.70–7) .0005 8/10
d best cross-validation (CV) consistency.
[7] Lifton RP. Molecular genetics of human blood pressure variation.
Sousa et al. Medicine (2017) 96:42 www.md-journal.comEssential hypertension is a multifactorial disease caused by
environmental, genetic, and individual lifestyle interactions that
lead to the onset of this pathology. Further studies are needed to
study gene–gene and gene-environment interactions and/or the
diversity of individual genetic and environmental characteristics
that lead to the development of EH.4.1. Study strengths and limitations
Wemust point out that this is thefirst studydonewith a population
from Madeira Island, a genetically homogenous and isolated
Southern European population. This has been especially valuable
for mapping rare recessive disorders, but many researchers believe
this could be a solution formore complex disorders aswell because
of the relatively uniform genetic background of the population.
Some culturally and genetically isolated populations have a more
similar way of living, eating habits, and natural environment,
which reduce environmental variation.[31]
A significant limitation of the study is the lack of biochemical
data on plasma renin, salt intake, and salt sensitivity, and other
confounders such as stress/anxiety levels and insomnia to explain
the specific physiological role of alpha-adducin polymorphism in
our population.
Another limitation is that hypertensives are included in the
study after their diagnosis and are already taking antihyperten-
sive therapy, for ethical reasons. In this study, only 38
hypertensive individuals were not medicated, which limits the
baseline BP assessment of individuals with and without this
genetic variant. It would be very interesting tomeasure the impact
of gene polymorphisms in relation to SBP and DBP.5. Conclusions
In summary, the present study shows that the ADD1 Gly460Trp
gene polymorphism is independently and significantly associated
with the EH risk amongst Madeira Island’s population. The
knowledge of the genetic polymorphisms associated with EH
could be widely used in clinical practice for diagnosis, treatment,
and prognosis of patients with essential hypertension.Acknowledgment
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